Liezl Gambe

Ramsay Santé presented its Connecting Care 2030, targeting annual revenue growth of approximately 3.0% through FY29.

Surgery Partners (NASDAQ:SGRY) updated its 2026 financial outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.

S&P Global (NYSE:SPGI) agreed to acquire OpenZeppelin, a provider of onchain security standards and smart contract technology, in a transaction announced September 17, 2026.

Indivior Pharmaceuticals (NASDAQ:INDV) declared a contingent special cash dividend of $8.13 per share, with payment dependent on the completion of its pending merger with Supernus Pharmaceuticals.

Sanofi (NASDAQ:SNY) and Cheplapharm announced plans to create a strategic partnership under which Cheplapharm would acquire a portfolio of 20 mature medicines and three manufacturing sites from Sanofi, with Sanofi receiving a 26.4% equity stake in Cheplapharm.

Innate Pharma (NASDAQ:IPHA) reported revenue and other income of €5.7 million for the first half of 2026, while posting a net loss of €19.6 million as the biotechnology company adjusted its research and development activities.

Ethereum developers have begun testing EIP-8411 to improve how quickly payloads spread across the network.

Seven Democratic senators have pledged to keep working on the CLARITY Act after its Senate vote failed.

Atlantic Lithium (ASX:A11) has secured Australian foreign investment approval for its proposed US$210 million scheme of arrangement with Zhejiang Huayou Cobalt.

Attackers claiming responsibility for the Revolut breach have demanded 6,000 Monero (CRYPTO:XMR), worth about US$3 million.